Table 2.
Treatment groups | ALT (U/L) | CCR1-positive NK cells × 105 |
---|---|---|
PBS + WT | 612 ± 58.1 | 0.31 ± 0.05 |
PBS + CCR5 KO | 13,020 ± 112* | 0.71 ± 0.10* |
Met-RANTES + CCR5 KO | 454 ± 32# | 0.35 ± 0.05# |
CCR5 KO mice were injected intravenously with either PBS or Met-RANTES (30 μg/mouse) as described in Materials and Methods. In addition, WT mice were injected with PBS. All mice were sacrificed at 8 hours after Con A administration for determination of plasma ALT levels and the number of CCR1-expressing NK cells in the liver as described in Materials and Methods. All data (n = 4 per group) are presented as means ± SEM.
P < 0.05 versus WT mice.
P < 0.05 versus PBS/CCR5 KO mice.